Does Tranexamic Acid Stop Your Period?

Tranexamic acid does not stop your period. It reduces how much you bleed, often substantially, but menstruation itself continues. Studies consistently show the drug cuts menstrual blood loss by roughly a quarter to over half, depending on the individual and how heavy the baseline bleeding is. That distinction matters because people sometimes expect this medication to work like a hormonal contraceptive that suppresses or eliminates periods altogether. Tranexamic acid is not hormonal, does not affect ovulation, and does not change when or whether you get your period. What it does is slow down the breakdown of blood clots in the uterine lining, so less blood leaves your body during each cycle.

What Tranexamic Acid Actually Does in the Uterus

When the uterine lining sheds during menstruation, small blood vessels open up. Your body forms clots to limit the bleeding, just as it would at any wound site. But the endometrium also produces enzymes that dissolve those clots, a process called fibrinolysis. In most people, there is a reasonable balance between clot formation and clot breakdown, and menstrual flow stays manageable.

In people with heavy menstrual bleeding, that balance tips. Research has found that women with heavy periods have significantly higher levels of clot-dissolving enzyme activity in their endometrial tissue during menstruation compared to women with normal flow.1PubMed. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia This excess fibrinolytic activity has also been observed in women using copper intrauterine devices, which are known to increase menstrual blood loss.2F&S Reviews. A systematic review of the plasminogen activator system in the endometrium and its role in menstruation and abnormal uterine bleeding

Tranexamic acid works by blocking this excess clot breakdown. It attaches to the sites on plasminogen, one of the key clot-dissolving proteins, and prevents it from latching onto and degrading fibrin, the structural protein in clots.3PubMed. Tranexamic acid: a review of its use in the management of menorrhagia The result: the natural clots that form at the shedding uterine lining stick around longer, and less blood escapes through those opened vessels. Your period still happens on schedule, your body still sheds the lining, but the volume of blood that comes out is reduced. This is why the drug is taken only during the heaviest days of menstruation rather than continuously throughout the month.

How Much Less Bleeding Should You Expect

The reduction varies, but the numbers from clinical trials are fairly consistent. A review of the evidence found that tranexamic acid reduces menstrual blood loss by somewhere between 26% and 60%, depending on the study and the patient population.4PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety In a placebo-controlled trial, women taking tranexamic acid saw their measured blood loss drop by about 40% on average, compared to about 8% in the placebo group.5Obstetrics & Gynecology. Tranexamic Acid Treatment for Heavy Menstrual Bleeding Another randomized trial found a reduction of about 54%, bringing average blood loss from roughly 143–178 mL per cycle down to 72–75 mL.6BMJ. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

To put that in practical terms, if you are soaking through a pad or tampon every hour during your heaviest days, tranexamic acid could bring that closer to every two or three hours. You might notice fewer large clots, less overnight leaking, and fewer days of heavy flow overall. But you will still bleed, and some people notice less improvement than others. A reduction of a quarter is on the low end of the range, and a reduction of more than half is on the high end. Where you land depends partly on how much excess fibrinolytic activity is driving your heavy bleeding in the first place.

How It Is Taken

Tranexamic acid for heavy periods is an oral tablet, typically taken three times a day during the heaviest days of menstruation, usually the first five days. In an adolescent study, the dose used was 1,300 mg three times daily for up to five days per cycle.7PubMed. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding Some prescribers adjust the dose depending on body weight or the severity of bleeding, but the general pattern is the same: you take it only while you are actively bleeding heavily, then stop until the next period.

This is a key practical difference from hormonal treatments. You do not take tranexamic acid every day. There is no “cycle” of pills to remember outside your period. There is no buildup period where the drug needs weeks to take effect. Most people notice a difference starting in the very first treated cycle, though the full benefit sometimes becomes more apparent after two or three cycles as iron stores begin recovering.

How It Compares to Other Treatments

People researching tranexamic acid often want to know how it stacks up against the other common options for heavy periods. The short answer is that it sits in the middle of the pack: more effective than anti-inflammatory painkillers, less effective than a hormonal IUD, and roughly comparable to combined oral contraceptives for reducing blood loss.

A Cochrane review found that NSAIDs as a group were less effective than tranexamic acid at reducing heavy menstrual bleeding.8PubMed Central. Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding The BMJ trial that tested both head-to-head quantified the gap: tranexamic acid cut blood loss by about 54%, while mefenamic acid (a prescription NSAID) reduced it by about 20%.6BMJ. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid For people with copper IUD-related heavy bleeding specifically, one study found that tranexamic acid and ibuprofen at standard doses had similar effects on blood loss volume and duration of menses.9Al-Azhar Assiut Medical Journal. A comparative study between the efficacy of tranexamic acid and ibuprofen for treatment of menorrhagia induced by copper T-380A intrauterine device

The levonorgestrel-releasing IUD, on the other hand, outperforms tranexamic acid by a wide margin. In a trial comparing both, the IUD reduced menstrual blood loss by about 82% after three months and nearly 96% after a year, compared to roughly 44% with tranexamic acid.10American Journal of Obstetrics and Gynecology. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia Many people with a hormonal IUD eventually stop bleeding almost entirely, something tranexamic acid cannot achieve. That said, an IUD is a hormonal device with its own set of side effects and is not an option for everyone. Tranexamic acid’s appeal is precisely that it offers a meaningful reduction in bleeding without introducing hormones.

A pilot study in adolescents found that tranexamic acid and combined oral contraceptives produced similar reductions in measured blood loss, with no significant difference between the two groups. Adolescents on oral contraceptives reported more drug-related side effects than those on tranexamic acid.11PubMed. Oral Tranexamic Acid versus Combined Oral Contraceptives for Adolescent Heavy Menstrual Bleeding: A Pilot Study That study was small, so the comparison should be taken cautiously, but it suggests that tranexamic acid can be a reasonable non-hormonal alternative for younger patients.

Safety and the Blood Clot Question

Because tranexamic acid works by preserving blood clots, the obvious concern is whether it might cause unwanted clots elsewhere in the body. This is the question that makes both patients and prescribers most nervous, and the evidence on it is more reassuring than the mechanism alone might suggest.

A large historical cohort study in Denmark found that oral tranexamic acid use for heavy menstrual bleeding was associated with a higher rate of venous blood clots compared to non-use. But the absolute numbers were very small. The extra risk worked out to roughly one additional venous clot for every 78,549 women using the drug for five days. For arterial clots, the increase was not statistically significant.12The Lancet. Venous and arterial thromboembolism with oral tranexamic acid for heavy menstrual bleeding: a nationwide historical cohort study in Denmark A separate case-control study using UK general practice data found a similarly elevated odds ratio for venous clots with recent tranexamic acid use, but this estimate did not reach statistical significance, likely because use was uncommon in the database.13PubMed. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database

In practical terms, the clot risk from a five-day course of tranexamic acid during menstruation appears to be quite low for most people. It is important context, though, if you already have risk factors for blood clots: a personal or family history of deep vein thrombosis or pulmonary embolism, use of estrogen-containing contraceptives, obesity, prolonged immobility, or a known clotting disorder. Prescribers generally screen for these before starting the medication. The drug is typically avoided in people with active clotting problems or a strong clotting history.

The most commonly reported side effects in clinical trials are more mundane: headache, nausea, abdominal discomfort, and back pain. These tend to be mild and often improve with continued use.

Heavy Periods from Bleeding Disorders

Heavy menstrual bleeding is sometimes caused by inherited bleeding conditions like von Willebrand disease, which affects how well blood clots form in the first place. Tranexamic acid is particularly useful in this population because it addresses clot stability without requiring factor replacement for every menstrual cycle.

A controlled trial in patients with von Willebrand disease found that tranexamic acid significantly reduced the number and severity of bleeding episodes and was associated with decreased use of clotting factor concentrates.14PubMed. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial A phase 3 crossover trial comparing tranexamic acid with recombinant von Willebrand factor in patients with mild to moderate von Willebrand disease found that tranexamic acid actually produced lower menstrual bleeding scores than the injected factor replacement, suggesting it can be a first-line option rather than a backup.15PubMed Central. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

For people with a diagnosed bleeding disorder, the appeal of tranexamic acid is that it can be taken orally at home, only during menstruation, without needing clinic visits for infusions. This is a real quality-of-life advantage for a group of patients who often deal with complicated treatment logistics on top of already difficult periods.

Effects on Iron Levels and Day-to-Day Life

One of the underappreciated consequences of chronically heavy periods is iron deficiency. When you lose a large volume of blood every month, your body’s iron stores gradually deplete, leading to low hemoglobin, fatigue, brain fog, and reduced exercise tolerance. Tranexamic acid does not contain iron, but by reducing the amount of blood you lose, it helps your body hold on to more iron each cycle.

In a study following patients over multiple treatment cycles, those who started with low hemoglobin saw meaningful increases. After three cycles, about a third of patients with low hemoglobin at baseline had shifted into the normal range. By 27 cycles, the proportion had risen to nearly half. Ferritin, the storage form of iron, improved more slowly but still substantially: after 27 cycles, about 58% of patients who started with low ferritin had recovered to normal levels.16PubMed. Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding

Beyond the lab numbers, people who take tranexamic acid for heavy periods consistently report improvements in daily functioning. A study measuring quality of life found substantial reductions in how much heavy bleeding interfered with social activities and work, along with improvements in alertness, productivity, and overall well-being.17PubMed. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding These softer outcomes matter as much as the blood loss numbers, because the real burden of heavy periods is not just the bleeding itself but the way it restricts what you can do and how you feel for a significant portion of each month.

Why People Confuse It with Period Suppression

The confusion between “reduces your period” and “stops your period” seems to come from a few places. Some people hear about tranexamic acid from friends or social media in casual terms: “it makes your period lighter,” which gets compressed to “it stops your period” in the retelling. Others see it prescribed alongside hormonal treatments and assume it works the same way. And there are situations where someone with extremely heavy flow takes tranexamic acid and goes from soaking through products every hour to having what feels like a normal period, which, compared to what they are used to, might feel like barely bleeding at all.

There is also a growing interest in using tranexamic acid to manage menstrual bleeding for convenience, such as delaying or reducing flow around vacations, athletic events, or religious observances. The drug does not delay periods or shift their timing. If you are looking for a way to skip a period entirely, hormonal options like continuous contraceptive pills or injections are the tools for that job. Tranexamic acid is a treatment for heavy bleeding, not a scheduling tool.

Copper IUD Users and Heavy Bleeding

Copper IUDs are popular because they provide highly effective non-hormonal contraception, but their most common downside is heavier, longer periods. This increased bleeding appears to involve the same mechanism tranexamic acid targets: copper IUDs are associated with greater fibrinolytic activity in the endometrial tissue.2F&S Reviews. A systematic review of the plasminogen activator system in the endometrium and its role in menstruation and abnormal uterine bleeding That makes tranexamic acid a logical option for people who want to keep their copper IUD but find the bleeding unmanageable.

A study comparing tranexamic acid and ibuprofen specifically in copper IUD users found both drugs had significant effects on blood loss volume and duration, with no clear winner between the two.9Al-Azhar Assiut Medical Journal. A comparative study between the efficacy of tranexamic acid and ibuprofen for treatment of menorrhagia induced by copper T-380A intrauterine device For this population, either option is reasonable, and some clinicians suggest trying ibuprofen first since it is available over the counter and also helps with cramping. If that does not reduce the bleeding enough, tranexamic acid is the next step before considering switching to a different contraceptive method.

Can You Combine It with Other Treatments

Because tranexamic acid is non-hormonal, it can often be used alongside hormonal contraceptives or other menstrual treatments. In practice, some people take it in addition to the pill, a hormonal IUD, or an NSAID like ibuprofen when one treatment alone is not enough. The pilot study of adolescents that compared tranexamic acid with combined oral contraceptives did not combine the two, but it demonstrated that tranexamic acid on its own was as effective as the pill for reducing measured blood loss.11PubMed. Oral Tranexamic Acid versus Combined Oral Contraceptives for Adolescent Heavy Menstrual Bleeding: A Pilot Study

The combination that gets the most caution is tranexamic acid with estrogen-containing contraceptives. Both carry some degree of clot risk, and using them together has historically made prescribers uneasy. In practice, the Danish cohort study and other data suggest that the absolute clot risk from tranexamic acid is low even when used alongside hormonal contraception, but this is still a conversation worth having with your prescriber, particularly if you have additional clot risk factors.12The Lancet. Venous and arterial thromboembolism with oral tranexamic acid for heavy menstrual bleeding: a nationwide historical cohort study in Denmark Combining tranexamic acid with an NSAID like ibuprofen is generally considered lower-risk since NSAIDs do not carry the same clotting concerns, and the two drugs work by different mechanisms.

When Tranexamic Acid Might Not Be the Right Choice

Tranexamic acid is specifically designed for heavy menstrual bleeding. If your periods are already normal in volume and you are hoping to eliminate them, this is not the right drug. It also will not help with other menstrual symptoms like cramping, bloating, or mood changes, since it only affects clot breakdown. NSAIDs and hormonal options have the advantage of addressing pain alongside flow.

It is also less effective than more aggressive interventions for people with very severe bleeding. Someone losing blood fast enough to need emergency care or transfusions likely needs a hormonal IUD, endometrial ablation, or surgical evaluation. Tranexamic acid works best as a first-line or second-line option for people whose heavy periods are disruptive but not immediately dangerous, or as an add-on therapy for people who are partially responding to another treatment. For bleeding disorders like von Willebrand disease, it can serve as a standalone treatment for mild to moderate cases but may need to be combined with clotting factor replacement in severe ones.14PubMed. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial